Novo Holdings tweaks fund to take antibiotics deeper into the clinic

Novo Holdings has changed the scope of its REPAIR Impact Fund to enable it to bankroll antibiotics for longer. REPAIR began life focused on projects between lead optimization and phase 1, but, in light of the tough funding environment for anti-infectives, will now support programs into phase 2.